Genzyme Sues Over Synthetic Vitamin D Patents
Biotechnology company Genzyme Corp. has sued Pentech Pharmaceuticals Inc. to prevent it from marketing a generic version of Hectorol, a synthetic form of Vitamin D used to treat secondary hyperparathyroidism in...To view the full article, register now.
Already a subscriber? Click here to view full article